Presentation Slides
[For attendees of the Digital Pathology Congress only]
| |
Presentation Slides [For attendees of the Digital Pathology Congress only] |
NB: You will see that not all the presenters from the conference are listed below. This is where the company or speaker have not given permission for release. This is usually due to corporate rules or because there was unpublished material in the presentation. In the case of the latter, we take the view that it is better to have exclusive presentations on the day, given before official publication, than to restrict the content of the conference by insisting on releasing such data in slide form, regardless of sensitivity or readiness for external examination. We hope you feel the same way. If you were a speaker and have not yet responded to our request for confirmation, please email scott@globalengage.co.uk to let us know if we can release your slides as a PDF. If there are issues with release, let me know if we need to remove your name from the page or whether there are smaller issues and we can share a revised version of the slides. These slides are provided as a courtesy by the authors, who retain copyright. This is not a publication and slides may be withdrawn at the authors request. |
Posters | Presentations AI &
COMPUTATIONAL PATHOLOGY
MARILYN BUI Professor of Pathology, President of Medical Staff and Director of Analytic Microscopy Core, Moffitt Cancer Center Unlash the Power of Digital Pathology and artificial intelligence for Precision Medicine KATRIEN GRÜNBERG Professor of Pathology & Head, Pathology Department, Radboud UMC Brave new world ** Awaiting Permission to Release ** MARIE-LOUISE LOUPART Image Analysis Specialist, Leica Biosystems Ten Years of Artificial Intelligence (AI) in Histology: Past, Present and Future ** Awaiting Permission to Release ** INES NEARCHOU Research fellow - Immuno-oncology, University of St. Andrews HALO and HALO AI for the development of prognostic signatures in colorectal cancer ** Awaiting Permission to Release ** DOUG HINERFELD Principal Product Application Scientist, NanoSting Technologies Solving the pathologist dilemma with Digital Spatial Profiling: The new quantitative, morphology driven, high- plex profiling technology ** Awaiting Permission to Release ** CHRISTIAN MÜNZENMAYER Head of Image Processing and Medical Engineering Department, Fraunhofer IIS High-throughput diagnostic system for tissue-based personalized cancer therapy DAVID WEST CEO, Proscia Inc. Global Trends and Pathology’s Tomorrow ** Awaiting Permission to Release ** KATE LILLARD Chief Scientific Officer, Indica Labs, Inc. HALO AI – Collaborative Deep Learning Platform for Pathology ** Awaiting Permission to Release ** SAMI BLOM Application Manager, Fimmic Oy AI-powered image analysis to enhance drug development in liver diseases ** Awaiting Permission to Release ** SYBREN MEIJER Consulting Histopathologist, Academic Medical Center, Amsterdam Man versus machine, expert histopathology risk stratification of Barrett’s neoplasia LASZLO IGALI, Consultant Histopathologist, Norfolk and Norwich University Hospitals FERENC IGALI, Lead Senior Technician, University of Lincoln VR and AR in pathology - why should we case? ** Awaiting Permission to Release ** DIGITAL PATHOLOGY STRATEGIES & TECHNOLOGIES DAVID SNEAD Consultant Histopathologist and Clinical Service Lead, Coventry and Warwickshire Pathology services (CWPS and UHCW NHS Trust) Disease processes by pixel analysis - the new era of digital pathology KURT ZATLOUKAL Diagnostic and Research Center for Molecular BioMedicine, Institute of Pathology, Medical University of Graz, Austria High throughput scanning in digital pathology ** Awaiting Permission to Release ** KATHARINA KÖHLER MVZ Prof. Dr. A. Niendorf Pathologie Hamburg-West GmbH Digital Pathology in a large scale breast cancer project using the 3DHISTECH Pannoramic 1000 Flash IV and QuantCenter ** Awaiting Permission to Release ** JACQUELINE JAMES Clinical Reader and Consultant Pathologist, Queens University Belfast Digital Pathology: Practical applications in Tissue Molecular Pathology ** Awaiting Permission to Release ** BEVERLY FAULKNERJONES Director of Digital Pathology, Beth Israel Deaconess Medical Center 3D and non-destructive imaging of surgical pathology specimens using nonlinear microscopy ** Awaiting Permission to Release ** ALEXI BAIDOSHVILI Histopathologist, Professor of Pathology, Director of Computational Pathology, LabPON, The Netherlands Microscope vs Digital Diagnostics: Improvements and Challenges in Logistic and Diagnostics after Digitalization in a Pathology Laboratory MICHAEL MCKENNA Clinical Lead for Pathology Services, Western Trust Digital Pathology in NI: Out with the old, in with the new ** Awaiting Permission to Release ** KAVITA ASWANI Senior Applications Scientist, Life Sciences, Excelitas Technologies Inc Soultion Provider Presentation ** Awaiting Permission to Release ** ROBERTO SPADA Market Development Specialist Fluidigm Soultion Provider Presentation ** Awaiting Permission to Release ** JUAN ANTONIO RETAMERO DÍAZ Pathologist, Granada Hospital Complete digital pathology for primary diagnosis: Thirty months’ experience at Granada University Hospitals, Spain DIGITAL IMAGE ANALYSIS CHLOE LOCKWOOD Laboratory Scientist, Leeds Teaching Hospitals NHS Trust and University of Leeds ISO Accreditation for Primary Digital diagnosis – How Did We Do It? ** Awaiting Permission to Release ** DAVID C. WILBUR Chief Medical Scientist, Corista & Professor of Pathology, Harvard Medical School The Right Interface – One of the Practical Keys to Practitioner Adoption in Digital Pathology ** Awaiting Permission to Release ** MARK ZARELLA Assistant Professor & Director, Advanced Pathology Imaging Lab, Drexel University, USA A cognitive model of whole-slide image viewing and interpretation PETER HAMILTON Head of Research, Philips Digital & Computational Pathology Seamless computational pathology for routine practice ** Awaiting Permission to Release ** KIMBERLY GASUAD, International Business Leader, Digital Pathology, Roche Diagnostics JOACHM SCHMID, Vice President of Research Development, Roche Diagnostics Digital Pathology Diagnostic Tools Today and Tomorrow ** Awaiting Permission to Release ** JENS RITTSCHER Professor of Engineering Science, University of Oxford Annotating Autonomously – Almost! ** Awaiting Permission to Release ** CASE STUDIES THOMAS MROWIEC Subject Matter Expert - Clinical Biomarker & Companion Diagnostics, Merck Digital Pathology in Drug Development - Strategies and Technologies to bridge Translational Biomarker Research and CDx ** Awaiting Permission to Release ** JOHN LE QUESNE Lead Pathologist, MRC Toxicology Unit, University of Leicester Quantitative digital pathology methods in solid tumour biology ** Awaiting Permission to Release ** RALF HUSS Chief Medical Officer, Definiens Tissue phenomics: digital pathology + integrative data science + computational intelligence ** Awaiting Permission to Release ** JONATHON LOPEZ Lyon University Hospital, France GeoMx digital space profiler: applications examples FILIPPO FRAGGETTA Head of the Pathology Unit, Cannizzaro Hospital, Catania, Italy Going fully digital with the Catania workflow: problems and solutions ** Awaiting Permission to Release ** DAVID C. WILBUR Chief Medical Scientist, Corista & Professor of Pathology, Harvard Medical School Implementation of AI Algorithms in the Laboratory Setting ** Awaiting Permission to Release **  Collation of all abstracts presented in poster form over the 2 days. Click Here For The Poster Summary Actual Posters submitted to share: Integrated analysis of digital pathology & multi-omic data for understanding the tumor micro-environment in precision immuno-oncology trials Kevin Teburi1, Marc Flesch2, Dirk Heckermann3, Harri Lempiäinen3, Tamas Rujan3 1Genedata Ltd, Cambridge, UK | 2Genedata GmbH, Munich, Germany | 3Genedata AG, Basel, Switzerland Evaluation of the stroma - a necessary parameter in the effective diagnosis of cancers. Example of papillary thyroid carcinoma. Author Name: Konstantin Maksin Co-Authors: Andrzej Kluk*, Magdalena Lewandowska**, Elżbieta Urasińska**, Sebastian Wołoszczuk***, Izabela Cichocka****, Łukasz Piątek****. * Poznan University of Medical Sciences, Poznan, Poland ** Department of Pathology, Faculty of Medicine Pomeranian Medical University, Szczecin, Poland *** Faculty of Physics, Adam Mickiewicz University, Poznan, Poland **** University of Information Technology and Management in Rzeszow, Poland Evaluating interobserver agreement when scoring randomized sets of digital slides of ductal carcinoma in situ: study design Emilie Groen1,2, Jan Hudecek2, Lindy Visser1, Lotte Elshof1, Lennart Mulder1, Michael Schaapveld3,Annegien Broeks4, Dennis Peters4, Hugo Horlings2, Esther Lips1, Jelle Wesseling1,3 1 Division of Molecular Pathology, 2 Department of Pathology, 3 Department of Psychosocial research and Epidemiology, 4 Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam |
|
For
further information on our events, please contact;
Steve Hambrook Conference Director steve@globalengage.co.uk +44 (0) 1865 849841 |
|
Copyright: Global Engage Ltd.
Registered in England. No: 6950636 |